drugset / Trial / NCT01039883

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

NCT01039883 ↗

Phase 1 Completed 40 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine whether albaconazole tablets and albaconazole capsules (single 400mg dose) act in the body in the same way over a period of time.

Timeline

Start
2009-11-23
Primary completion
2010-01-20
Completion
2010-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Albaconazole Small molecule 400 mg Oral

Indications